Extensively drug-resistant Acinetobacter baumannii lung abscess and empyema in a patient with fulminant mycoplasma pneumoniae pneumonia

被引：0
作者：
Yang, Siyu [1 ]
Wei, Chaojie [1 ]
机构：
[1] Wuhan Univ, Dept Pulm & Crit Care Med, Zhongnan Hosp, Wuhan, Peoples R China
来源：
RESPIRATORY MEDICINE CASE REPORTS | 2025年 / 53卷
关键词：
Fulminant Mycoplasma pneumoniae; pneumonia; XDR Acinetobacter baumannii; Lung abscess; Empyema; Carrimycin; CARRIMYCIN;
D O I：
10.1016/j.rmcr.2024.102150
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
Acinetobacter baumannii is a pathogen that typically causes nosocomial infections. Its resistance to multiple antibiotics poses significant challenges for treatment. Fulminant Mycoplasma pneumoniae pneumonia (FMPP) is relatively rare despite Mycoplasma pneumoniae pneumonia is common among children and young adults. We present a case involving the concurrence of FMPP and lung abscess and empyema caused by extensively drug-resistant (XDR) A.baumanii. The patient was successfully treated through a novel and effective antibacterial regimen combined with timely drainage.
引用
收藏
页数：6
相关论文
共 17 条
  • [1] CHAN ED, 1995, WESTERN J MED, V162, P133
  • [2] Management of pleural infection in adults: British Thoracic Society pleural disease guideline 2010
    Davies, Helen E.
    Davies, Robert J. O.
    Davies, Christopher W. H.
    [J]. THORAX, 2010, 65 : 41 - 53
  • [3] Carrimycin, as One of the Drugs in Combination Therapy, for the Treatment of Carbapenem-Resistant Acinetobacter Baumannii Infection
    Du, Ning
    You, Dan
    Tenzing, Dava
    Qu, Dongxiang
    Meng, Jun
    Wang, Yihui
    He, Juan
    [J]. INFECTION AND DRUG RESISTANCE, 2024, 17 : 3617 - 3621
  • [4] Uncovering the mechanisms of Acinetobacter baumannii virulence
    Harding, Christian M.
    Hennon, Seth W.
    Feldman, Mario F.
    [J]. NATURE REVIEWS MICROBIOLOGY, 2018, 16 (02) : 91 - 102
  • [5] Clinical Features of Severe or Fatal Mycoplasma pneumoniae Pneumonia
    Izumikawa, Koichi
    [J]. FRONTIERS IN MICROBIOLOGY, 2016, 7
  • [6] Increased rates of intensive care unit admission in patients with Mycoplasma pneumoniae: a retrospective study
    Khoury, T.
    Sviri, S.
    Rmeileh, A. A.
    Nubani, A.
    Abutbul, A.
    Hoss, S.
    van Heerden, P. V.
    Bayya, A. E.
    Hidalgo-Grass, C.
    Moses, A. E.
    Nir-Paz, R.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2016, 22 (08) : 711 - 714
  • [7] EFFECT OF BRANCHED-CHAIN AMINO ACIDS, VALINE, ISOLEUCINE AND LEUCINE ON THE BIOSYTHESIS OF BITESPIRAMYCIN 4"-O-ACYLSPIRAMYCINS
    Li, Zhen-Lin
    Wang, Yong-Hong
    Chu, Ju
    Zhang, Ying-Ping Zhuang Si-Liang
    [J]. BRAZILIAN JOURNAL OF MICROBIOLOGY, 2009, 40 (04) : 734 - 746
  • [8] Construction of 4"-Isovalerylspiramycin-I-Producing Strain by In-Frame Partial Deletion of 3-O-Acyltransferase Gene in Streptomyces spiramyceticus WSJ-1, the Bitespiramycin Producer
    Ma, Chunyan
    Zhou, Hongxia
    Li, Jingyan
    Dai, Jianlu
    He, Weiqing
    Wang, Hongyuan
    Wu, Linzhuan
    Wang, Yiguang
    [J]. CURRENT MICROBIOLOGY, 2011, 62 (01) : 16 - 20
  • [9] Mwandumba H C, 2000, Curr Opin Pulm Med, V6, P234, DOI 10.1097/00063198-200005000-00012
  • [10] Recent Advances in Anti-Metastatic Approaches of Herbal Medicines in 5 Major Cancers: From Traditional Medicine to Modern Drug Discovery
    Park, Jinkyung
    Jeong, Dahee
    Song, Meeryoung
    Kim, Bonglee
    [J]. ANTIOXIDANTS, 2021, 10 (04)
12